{"id":82658,"date":"2025-11-18T13:53:00","date_gmt":"2025-11-18T13:53:00","guid":{"rendered":"https:\/\/www.cofb.org\/?p=82658"},"modified":"2025-11-20T13:03:28","modified_gmt":"2025-11-20T13:03:28","slug":"rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/","title":{"rendered":"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament"},"content":{"rendered":"\n

El passat 28 d\u2019octubre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/strong> (COFB) va organitzar la formaci\u00f3 \u201cRinosinusitis i congesti\u00f3 nasal: novetats basades en l’evid\u00e8ncia i reducci\u00f3 de l’\u00fas d’antibi\u00f2tics<\/strong>\u201d, amb el patrocini de Bionorica<\/a>. La confer\u00e8ncia va anar a c\u00e0rrec de Manuel Bernal<\/strong>, cap del Servei d’Otorrinoralingologia (ORL) de l’Hospital Cl\u00ednic de Barcelona; i d\u2019Elena P\u00e9rez<\/strong>, farmac\u00e8utica titular de la farm\u00e0cia Garc\u00eda P\u00e9rez a L’Hospitalet de Llobregat. La formaci\u00f3 va ser coordinada pel vocal de Plantes Medicinals i Homeopatia del COFB, Josep Allu\u00e9<\/strong>.<\/p>\n\n\n\n

Els objectius <\/strong>de la sessi\u00f3 van ser revisar les situacions m\u00e9s freq\u00fcents<\/strong> que cursen amb congesti\u00f3 nasal<\/strong>, con\u00e8ixer les opcions terap\u00e8utiques disponibles <\/strong>i presentar l’evid\u00e8ncia cient\u00edfica m\u00e9s recent <\/strong>sobre l’\u00fas de medicaments a base de plantes<\/strong>.<\/p>\n\n\n\n

\"El<\/a>
El vocal de Plantes Medicinals del COFB, Josep Allu\u00e9, en la seva presentaci\u00f3.<\/figcaption><\/figure>\n\n\n\n

Josep Allu\u00e9<\/strong>, vocal de Plantes Medicinals del COFB, va inaugurar la formaci\u00f3 afirmant que \u201cmedicaments amb bases de plantes<\/strong> a diferents pa\u00efsos europeus s\u00f3n una refer\u00e8ncia. La pres\u00e8ncia d\u2019aquests medicaments solucionar\u00e0 molts problemes a la pr\u00e0ctica di\u00e0ria de l\u2019oficina de farm\u00e0cia<\/strong> pel que fa a les congestions nasals<\/strong>. Tots coneixem les limitacions existents en aquest aspecte\u201d.<\/p>\n\n\n\n

Rinosinusitis i la integraci\u00f3 de la fitoter\u00e0pia a les guies cl\u00edniques<\/h2>\n\n\n\n

Manuel Bernal<\/strong>, cap de Servei d’ORL de l’Hospital Cl\u00ednic de Barcelona, va iniciar la seva sessi\u00f3 explicant que \u201cla congesti\u00f3 nasal <\/strong>sempre est\u00e0 dins el marc d\u2019alguna afectaci\u00f3 rinosinusal<\/strong>. Amb el pas dels anys, han aparegut tractaments innovadors a base de fitof\u00e0rmacs <\/strong>contra la congesti\u00f3 nasal, arribant fins i tot a usar-los en detriment dels antibi\u00f2tics<\/strong> a causa de la seva efici\u00e8ncia\u201d.<\/p>\n\n\n\n

La definici\u00f3 cl\u00ednica de la rinosinusitis<\/strong> \u201cha anat modificant-se a trav\u00e9s del pas del temps. Quan un pacient la pateix durant m\u00e9s de deu dies, es tracta d\u2019una rinosinusitis aguda<\/strong>. A partir de les dues setmanes<\/strong>, s\u2019hauria de parlar de rinosinsutis cr\u00f2nica<\/strong>, que genera una obstrucci\u00f3 nasal que no pot eliminar-se amb antibi\u00f2tic, es necessita un altre tipus d\u2019abordatge terap\u00e8utic\u201d, va explicar Bernal.<\/p>\n\n\n\n

\"Manuel<\/a>
Manuel Bernal, en un moment de la seva presentaci\u00f3.<\/figcaption><\/figure>\n\n\n\n

Per finalitzar la seva pon\u00e8ncia lligada a rinosinusitis i congesti\u00f3 nasal, Bernal va esmentar la integraci\u00f3 de la fitoter\u00e0pia<\/strong> en les guies cl\u00edniques lligades a la rinosinusitis<\/strong>: \u201cEls \u00faltims descobriments han respost a les expectatives dels pacients de rebre un tractament actiu<\/strong>, convertint a aquesta ter\u00e0pia en una soluci\u00f3 efica\u00e7, segura i avalada pels investigadors\u201d.<\/p>\n\n\n\n

Plantes medicinals i el paper del farmac\u00e8utic<\/h2>\n\n\n\n

A continuaci\u00f3, Elena P\u00e9rez<\/strong>, farmac\u00e8utica titular de la farm\u00e0cia Garc\u00eda P\u00e9rez a L’Hospitalet de Llobregat, va explicar la seva experi\u00e8ncia a la farm\u00e0cia lligada al consum de plantes medicinals<\/strong>: \u201cCada vegada hi ha m\u00e9s demanda d\u2019aquests productes, i per aix\u00f2 es tracta d\u2019una oportunitat<\/strong>. Per tant, \u00e9s necessari formar-se per poder donar resposta a tots els pacients <\/strong>que demanen per aquest grup de f\u00e0rmacs\u201d.<\/p>\n\n\n\n

La farmac\u00e8utica va especificar que, cada vegada, \u201chi ha m\u00e9s gent que s\u2019informa de les plantes medicinals<\/strong> \u00fanicament per xarxes socials<\/strong> i quan arriben a la farm\u00e0cia tenen molts dubtes. \u00c9s aqu\u00ed on el professional ha d\u2019ordenar i aclarir tota la informaci\u00f3 <\/strong>respecte a aquest camp\u201d.<\/p>\n\n\n\n

\"La<\/a>
La farmac\u00e8utica Elena P\u00e9rez, en un moment de la seva exposici\u00f3.<\/figcaption><\/figure>\n\n\n\n

Per concloure la seva pon\u00e8ncia, P\u00e9rez va destacar que \u201cel 70% d\u2019espanyols consumeix plantes medicinals<\/strong>, ja que es prefereix una soluci\u00f3 natural que medicaci\u00f3 sint\u00e8tica. La societat percep que \u00e9s m\u00e9s natural i t\u00e9 menys efectes secundaris. Tot aix\u00f2 ajuda que els farmac\u00e8utics hagin de formar als seus equips dels productes naturals que es venen a les farm\u00e0cies\u201d. En darrer lloc, va compartir que el farmac\u00e8utic \u201cha de donar un bon consell en l\u2019\u00e0mbit de medicaments naturals o sint\u00e8tics<\/strong>. Hi ha una gran evid\u00e8ncia cient\u00edfica darrere, fet que ha de generar tranquil\u00b7litat a l\u2019hora de poder-lo aconsellar al pacient\u201d.<\/p>\n\n\n\n

Amb el patrocini de:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

El passat 28 d\u2019octubre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la formaci\u00f3 \u201cRinosinusitis i congesti\u00f3 nasal: novetats basades en l’evid\u00e8ncia i reducci\u00f3 de l’\u00fas d’antibi\u00f2tics\u201d, amb el patrocini de Bionorica. La confer\u00e8ncia va anar a c\u00e0rrec de Manuel Bernal, cap del Servei d’Otorrinoralingologia (ORL) de l’Hospital Cl\u00ednic […]<\/p>\n","protected":false},"author":10,"featured_media":82665,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[269,18,19,69,70,431,2976],"class_list":["post-82658","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-antibiotics","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-farmacia-comunitaria","tag-formacio","tag-planta-medicinal","tag-vocalia-de-plantes-medicinals"],"yoast_head":"\nRinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/ca\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/ca\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-18T13:53:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-20T13:03:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Xavier Magraner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Xavier Magraner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\"},\"author\":{\"name\":\"Xavier Magraner\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\"},\"headline\":\"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament\",\"datePublished\":\"2025-11-18T13:53:00+00:00\",\"dateModified\":\"2025-11-20T13:03:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\"},\"wordCount\":719,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg\",\"keywords\":[\"antibi\u00f2tics\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"farm\u00e0cia comunit\u00e0ria\",\"Formaci\u00f3\",\"planta medicinal\",\"Vocalia de Plantes Medicinals\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\",\"url\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\",\"name\":\"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg\",\"datePublished\":\"2025-11-18T13:53:00+00:00\",\"dateModified\":\"2025-11-20T13:03:28+00:00\",\"description\":\"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\",\"name\":\"Xavier Magraner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"caption\":\"Xavier Magraner\"},\"url\":\"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/ca\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/","og_locale":"ca_ES","og_type":"article","og_title":"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica","og_url":"https:\/\/www.cofb.org\/ca\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2025-11-18T13:53:00+00:00","article_modified_time":"2025-11-20T13:03:28+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg","type":"image\/jpeg"}],"author":"Xavier Magraner","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"Xavier Magraner","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/"},"author":{"name":"Xavier Magraner","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4"},"headline":"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament","datePublished":"2025-11-18T13:53:00+00:00","dateModified":"2025-11-20T13:03:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/"},"wordCount":719,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg","keywords":["antibi\u00f2tics","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","farm\u00e0cia comunit\u00e0ria","Formaci\u00f3","planta medicinal","Vocalia de Plantes Medicinals"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/","url":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/","name":"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg","datePublished":"2025-11-18T13:53:00+00:00","dateModified":"2025-11-20T13:03:28+00:00","description":"El COFB celebra a la seva seu una nova formaci\u00f3 lligada a rinosinusitis i congesti\u00f3 nasal, amb el patrocini de Bionorica","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2025\/11\/18\/rinosinusitis-i-congestio-nasal-novetats-en-el-seu-tractament\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Rinosinusitis i congesti\u00f3 nasal: novetats en el seu tractament"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4","name":"Xavier Magraner","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","caption":"Xavier Magraner"},"url":"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/RINOSINUSITIS_COFB_03112025_02-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Xavier Magraner","author_link":"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 28 d\u2019octubre, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar la formaci\u00f3 \u201cRinosinusitis i congesti\u00f3 nasal: novetats basades en l’evid\u00e8ncia i reducci\u00f3 de l’\u00fas d’antibi\u00f2tics\u201d, amb el patrocini de Bionorica. La confer\u00e8ncia va anar a c\u00e0rrec de Manuel Bernal, cap del Servei d’Otorrinoralingologia (ORL) de l’Hospital Cl\u00ednic […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/82658","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=82658"}],"version-history":[{"count":12,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/82658\/revisions"}],"predecessor-version":[{"id":82901,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/82658\/revisions\/82901"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/82665"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=82658"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=82658"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=82658"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}